Af­ter cross­ing t's, dot­ting i's, Im­muno­core nails down break­through ther­a­py des­ig­na­tion for lead TCR ther­a­py

Days af­ter tap­ping a new com­mer­cial head, Im­muno­core has scored a break­through ther­a­py des­ig­na­tion for its lead T cell re­cep­tor pro­gram, which it plans on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER